MY155011A - Hydroxy tetrahydro-naphthalenylurea derivatives - Google Patents

Hydroxy tetrahydro-naphthalenylurea derivatives

Info

Publication number
MY155011A
MY155011A MYPI20031696A MYPI20031696A MY155011A MY 155011 A MY155011 A MY 155011A MY PI20031696 A MYPI20031696 A MY PI20031696A MY PI20031696 A MYPI20031696 A MY PI20031696A MY 155011 A MY155011 A MY 155011A
Authority
MY
Malaysia
Prior art keywords
pain
treatment
hydroxy tetrahydro
tetrahydro
activity
Prior art date
Application number
MYPI20031696A
Other languages
English (en)
Inventor
Takeshi Yura
Masaomi Tjimi
Yasuhiro Tsukimi
Noriyuki Yamamoto
Muneto Mogi
Klaus Dr Urbahns
Hiroshi Fujishima
Tsutomu Masuda
Toshiya Moriwaki
Nagahiro Yoshida
Toshio Kokubo
Masahiro Shiroo
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MY155011A publication Critical patent/MY155011A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
MYPI20031696A 2002-05-08 2003-05-06 Hydroxy tetrahydro-naphthalenylurea derivatives MY155011A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0210512.0A GB0210512D0 (en) 2002-05-08 2002-05-08 Tetrahydro-napthalene derivatives
GBGB0227262.3A GB0227262D0 (en) 2002-05-08 2002-11-21 Tetrahydro-naphthalene derivatives

Publications (1)

Publication Number Publication Date
MY155011A true MY155011A (en) 2015-08-28

Family

ID=9936269

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20031696A MY155011A (en) 2002-05-08 2003-05-06 Hydroxy tetrahydro-naphthalenylurea derivatives

Country Status (13)

Country Link
KR (1) KR101000688B1 (es)
AR (1) AR039983A1 (es)
CU (1) CU23422B7 (es)
DO (1) DOP2003000642A (es)
EC (1) ECSP045413A (es)
GB (2) GB0210512D0 (es)
GT (1) GT200300102A (es)
MA (1) MA30728B1 (es)
MY (1) MY155011A (es)
PE (1) PE20040363A1 (es)
PT (1) PT1506167E (es)
UA (1) UA77301C2 (es)
ZA (1) ZA200408993B (es)

Also Published As

Publication number Publication date
AR039983A1 (es) 2005-03-09
MA30728B1 (fr) 2009-10-01
PE20040363A1 (es) 2004-07-03
KR101000688B1 (ko) 2010-12-10
ECSP045413A (es) 2005-01-03
GT200300102A (es) 2004-03-17
ZA200408993B (en) 2006-01-25
GB0210512D0 (en) 2002-06-19
GB0227262D0 (en) 2002-12-31
KR20040108784A (ko) 2004-12-24
UA77301C2 (en) 2006-11-15
CU23422B7 (es) 2009-09-08
DOP2003000642A (es) 2003-11-15
PT1506167E (pt) 2007-12-10

Similar Documents

Publication Publication Date Title
HK1082946A1 (en) Hydroxy tetrahydro-naphthalenyurea derivatives
AU2003294748A1 (en) Tetrahydro-naphthalene derivatives
IL214198A0 (en) Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling
WO2005112970A3 (en) Use of gelsolin to treat infections
EP1893216A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
EP1879578A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
PT1881823E (pt) Composições e métodos para o tratamento de transtornos oculares
TW200612934A (en) Quaternary salt CCR2 antagonists
EP2248524A3 (en) Preventives/remedies for stress urinary incontinence and method of screening the same
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
IL184371A0 (en) Methods of treating skin disorders using an il-31ra antagonist
ZA200610661B (en) Compositions and methods for treating neurological disorders
WO2010091384A3 (en) Cadherin-11 inhibitors and methods of use thereof
WO2007051785A3 (en) Use of sdf-1 for the treatment and/or prevention of neurological diseases
IL189009A0 (en) Methods and compositions for the treatment of neuropathies and related disorders
WO2006081516A3 (en) USE OF BAFF TO TREAT Th2-MEDIATED CONDITIONS
AU2003288200A1 (en) Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
WO2006079068A3 (en) Compositions and methods for studying and treating inflammatory diseases and disorders
TWI369984B (en) Pharmaceutical compositions for treatment of overactive bladder associated with neurological disorders
MY155011A (en) Hydroxy tetrahydro-naphthalenylurea derivatives
IL181713A0 (en) Use of il-17f for the treatment and/or prevention of neurological diseases
WO2007117289A3 (en) Methods for treating or preventing erectile dysfunction or urinary incontinence
AU2005902597A0 (en) Compositions and methods for treatment of sexual dysfunction
ZA200805859B (en) Methods and compositions for the treatment of gastriontestinal disorders